Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neuropsychology Review
Published in: Neuropsychology Review 2/2009

Open Access 01-06-2009 | Review

Neuropsychological Assessment of HIV-Infected Populations in International Settings

Authors: Kevin Robertson, Jeff Liner, Robert Heaton

Published in: Neuropsychology Review | Issue 2/2009

Login to get access

Abstract

Resource-limited regions of the world represent the areas most affected by the global HIV epidemic. Currently, there are insufficient data on the neurocognitive effects of HIV in these areas and neuropsychological studies that have been carried out thus far are marked by inconsistent methods, test batteries, and rating systems for levels of cognitive impairment. These differences in methods, along with genetic variability of both virus and host, differences in co-infections and other co-morbidities, differences in language and culture, and infrastructural deficiencies in many international settings create challenges to the assessment of neurocognitive functioning and interpretation of neuropsychological data. Identifying neurocognitive impairment directly attributable to HIV, exploring relationships between HIV-associated neurocognitive impairment, disease variables, and everyday functioning, evaluating differences in HIV-1 subtype associated neuropathology, and determining implications for treatment remain complicated and challenging goals. Endeavors to establish a more standardized approach to neurocognitive assessments across international studies in addition to accumulating appropriate normative data that will allow more accurate rating of neuropsychological test performance will be crucial to future efforts attempting to achieve these goals.
Literature
AAN. (1991). Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a working group of the American academy of neurology aids task force. Neurology, 41(6), 778–785.
Agranovich, A. V., & Puente, A. E. (2007). Do Russian and American normal adults perform similarly on neuropsychological tests? Preliminary findings on the relationship between culture and test performance. Archives of Clinical Neuropsychology, 22(3), 273–282.CrossRefPubMed
An, S. F., Groves, M., Gray, F., & Scaravilli, F. (1999). Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. Journal of Neuropathology and Experimental Neurology, 58(11), 1156–1162.CrossRefPubMed
Anger, W. K., Cassitto, M. G., Liang, Y. X., Amador, R., Hooisma, J., Chrislip, D. W., et al. (1993). Comparison of performance from three continents on the WHO-recommended neurobehavioral core test battery. Environmental Research, 62(1), 125–147.CrossRefPubMed
Anger, W. K., Liang, Y. X., Nell, V., Kang, S. K., Cole, D., Bazylewicz-Walczak, B., et al. (2000). Lessons learned—15 years of the WHO-NCTB: a review. Neurotoxicology, 21(5), 837–846.PubMed
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., et al. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69(18), 1789–1799.CrossRefPubMed
Archibald, S. L., Masliah, E., Fennema-Notestine, C., Marcotte, T. D., Ellis, R. J., McCutchan, J. A., et al. (2004). Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. Archives of Neurology, 61(3), 369–376.CrossRefPubMed
Behnisch, T., Francesconi, W., & Sanna, P. P. (2004). HIV secreted protein Tat prevents long-term potentiation in the hippocampal CA1 region. Brain Research, 1012(1–2), 187–189.CrossRefPubMed
Belec, L., Martin, P. M., Vohito, M. D., Gresenguet, G., Tabo, A., & Georges, A. J. (1989). Low prevalence of neuro-psychiatric clinical manifestations in central African patients with acquired immune deficiency syndrome. Transactions of the Royal Society of Tropical Medicine and Hygiene, 83(6), 844–846.CrossRefPubMed
Boivin, M. J., Giordani, B., & Bornefeld, B. (1995). Use of the Tactual Performance Test for cognitive ability testing with African children. Neuropsychology, 9(3), 409–417.CrossRef
Bornstein, R. A., Nasrallah, H. A., Para, M. F., Whitacre, C. C., Rosenberger, P., & Fass, R. J. (1993). Neuropsychological performance in symptomatic and asymptomatic HIV infection. Aids, 7(4), 519–524.CrossRefPubMed
Butters, N., Grant, I., Haxby, J., Judd, L. L., Martin, A., McClelland, J., et al. (1990). Assessment of aids-related cognitive changes: recommendations of the NIMH workshop on neuropsychological assessment approaches. Journal of Clinical and Experimental Neuropsychology, 12(6), 963–978.CrossRefPubMed
Byrd, D. A., Touradji, P., Tang, M. X., & Manly, J. J. (2004). Cancellation test performance in African American, Hispanic, and white elderly. Journal of the International Neuropsychological Society , 10(3), 401–411.CrossRefPubMed
Cherner, M., Cysique, L., Heaton, R. K., Marcotte, T. D., Ellis, R. J., Masliah, E., et al. (2007). Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. Journal of Neurovirology, 13(1), 23–28.CrossRefPubMed
Chiodi, F., Keys, B., Albert, J., Hagberg, L., Lundeberg, J., Uhlen, M., et al. (1992). Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals. Journal of Clinical Microbiology , 30(7), 1768–1771.PubMed
Chung, J. H., Sakong, J., Kang, P. S., Kim, C. Y., Lee, K. S., Jeon, M. J., et al. (2003). Cross-cultural comparison of neurobehavioral performance in Asian workers. Neurotoxicology, 24(4–5), 533–540.CrossRefPubMed
Clifford, D. B., Mitike, M. T., Mekonnen, Y., Zhang, J., Zenebe, G., Melaku, Z., et al. (2007). Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. Journal of Neurovirology, 13(1), 67–72.CrossRefPubMed
Cysique, L. A., Deutsch, R., Atkinson, J. H., Young, C., Marcotte, T. D., Dawson, L., et al. (2007a). Incident major depression does not affect neuropsychological functioning in HIV-infected men. Journal of the International Neuropsychological Society, 13(1), 1–11.CrossRefPubMed
Cysique, L. A., Jin, H., Franklin, D. R., Jr., Morgan, E. E., Shi, C., Yu, X., et al. (2007b). Neurobehavioral effects of HIV-1 infection in china and the United States: a pilot study. Journal of the International Neuropsychological Society, 13(5), 781–790.CrossRefPubMed
d’Arminio Monforte, A., Cinque, P., Mocroft, A., Goebel, F. D., Antunes, F., Katlama, C., et al. (2004). Changing incidence of central nervous system diseases in the EuroSIDA cohort. Annals of Neurology, 55(3), 320–328.CrossRefPubMed
Davis, L. E., Hjelle, B. L., Miller, V. E., Palmer, D. L., Llewellyn, A. L., Merlin, T. L., et al. (1992). Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology, 42(9), 1736–1739.PubMed
Dawes, S., Suarez, P., Casey, C. Y., Cherner, M., Marcotte, T. D., Letendre, S., et al. (2008). Variable patterns of neuropsychological performance in HIV-1 infection. Journal of Clinical and Experimental Neuropsychology, 30(6), 613–626.CrossRefPubMed
Dreyer, E. B., Kaiser, P. K., Offermann, J. T., & Lipton, S. A. (1990). HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science, 248(4953), 364–367.CrossRefPubMed
Epstein, L. G., & Gendelman, H. E. (1993). Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Annals of Neurology, 33(5), 429–436.CrossRefPubMed
Everall, I. P., Heaton, R. K., Marcotte, T. D., Ellis, R. J., McCutchan, J. A., Atkinson, J. H., et al. (1999). Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC group. HIV neurobehavioral research center. Brain Pathology, 9(2), 209–217.PubMed
Gao, F., Bailes, E., Robertson, D. L., Chen, Y., Rodenburg, C. M., Michael, S. F., et al. (1999). Origin of HIV-1 in the chimpanzee pan troglodytes troglodytes. Nature, 397(6718), 436–441.CrossRefPubMed
Gendelman, H. E., Genis, P., Jett, M., Zhai, Q. H., & Nottet, H. S. (1994). An experimental model system for HIV-1-induced brain injury. Advances in Neuroimmunology, 4(3), 189–193.CrossRefPubMed
Goggin, K. J., Zisook, S., Heaton, R. K., Atkinson, J. H., Marshall, S., McCutchan, J. A., et al. (1997). Neuropsychological performance of HIV-1 infected men with major depression. HNRC group. HIV neurobehavioral research center. Journal of the International Neuropsychological Society, 3(5), 457–464.PubMed
Gordon, R. G., Jr. (2005). Ethnologue: Languages of the world, 15th edition: SIL International.
Grant, I., Atkinson, J. H., Hesselink, J. R., Kennedy, C. J., Richman, D. D., Spector, S. A., et al. (1987). Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Annals of Internal Medicine, 107(6), 828–836.PubMed
Gupta, J. D., Satishchandra, P., Gopukumar, K., Wilkie, F., Waldrop-Valverde, D., Ellis, R., et al. (2007). Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. Journal of Neurovirology, 13(3), 195–202.CrossRefPubMed
Heaton, R. K., Grant, I., Butters, N., White, D. A., Kirson, D., Atkinson, J. H., et al. (1995). The HNRC 500—neuropsychology of HIV infection at different disease stages. HIV neurobehavioral research center. Journal of the International Neuropsychological Society, 1(3), 231–251.CrossRefPubMed
Heaton, R. K., Cysique, L. A., Jin, H., Shi, C., Yu, X., Letendre, S., et al. (2008). Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in Rural China. J Neurovirol, 1–14.
Heaton, R., Franklin, D., Clifford, D., Woods, S., Rivera Mindt, M. (2009). HIV-associated neurocognitive impairment remains prevalent in the era of combination art: The charter study. Paper presented at the 16th Conference on Retroviruses and Opportunistic Infections, Montreal.
Hedden, T., Park, D. C., Nisbett, R., Ji, L. J., Jing, Q., & Jiao, S. (2002). Cultural variation in verbal versus spatial neuropsychological function across the life span. Neuropsychology, 16(1), 65–73.CrossRefPubMed
Hemelaar, J., Gouws, E., Ghys, P. D., & Osmanov, S. (2006). Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. Aids, 20(16), W13–W23.CrossRefPubMed
Holding, P. A., Taylor, H. G., Kazungu, S. D., Mkala, T., Gona, J., Mwamuye, B., et al. (2004). Assessing cognitive outcomes in a rural African population: development of a neuropsychological battery in Kilifi district, Kenya. Journal of the International Neuropsychological Society, 10(2), 246–260.CrossRefPubMed
Howlett, W. P., Nkya, W. M., Mmuni, K. A., & Missalek, W. R. (1989). Neurological disorders in aids and HIV disease in the northern zone of Tanzania. Aids, 3(5), 289–296.CrossRefPubMed
Hsieh, S. L., & Tori, C. D. (2007). Normative data on cross-cultural neuropsychological tests obtained from mandarin-speaking adults across the life span. Archives of Clinical Neuropsychology, 22(3), 283–296.CrossRefPubMed
Jahoda, G. (1979). On the nature of difficulties in spatial-perceptual tasks: ethnic and sex differences. British Journal of Psychology, 70(3), 351–363.PubMed
Jones, M., Olafson, K., Del Bigio, M. R., Peeling, J., & Nath, A. (1998). Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. Journal of Neuropathology and Experimental Neurology, 57(6), 563–570.CrossRefPubMed
Kaleebu, P., French, N., Mahe, C., Yirrell, D., Watera, C., Lyagoba, F., et al. (2002). Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes a and d on disease progression in a large cohort of HIV-1-positive persons in Uganda. Journal of Infectious Diseases, 185(9), 1244–1250.CrossRefPubMed
Kramer-Hammerle, S., Rothenaigner, I., Wolff, H., Bell, J. E., & Brack-Werner, R. (2005). Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Research, 111(2), 194–213.CrossRefPubMed
Kure, K., Lyman, W. D., Weidenheim, K. M., & Dickson, D. W. (1990). Cellular localization of an HIV-1 antigen in subacute aids encephalitis using an improved double-labeling immunohistochemical method. American Journal of Pathology, 136(5), 1085–1092.PubMed
Laeyendecker, O., Li, X, Arroyo, M, McCutchan, F, et al. (2006). The effect of HIV subtype on rapid disease progression in Rakai, Uganda. 13th Conference on Retroviruses and Opportunistic Infections. Denver, CO.
Lannuzel, A., Lledo, P. M., Lamghitnia, H. O., Vincent, J. D., & Tardieu, M. (1995). HIV-1 envelope proteins gp120 and gp160 potentiate NMDA-induced [ca2+]i increase, alter [ca2+]i homeostasis and induce neurotoxicity in human embryonic neurons. European Journal of Neuroscience, 7(11), 2285–2293.CrossRefPubMed
Levi, G., Patrizio, M., Bernardo, A., Petrucci, T. C., & Agresti, C. (1993). Human immunodeficiency virus coat protein gp120 inhibits the beta-adrenergic regulation of astroglial and microglial functions. Proceedings of the National Academy of Sciences of the United States of America, 90(4), 1541–1545.CrossRefPubMed
Liner, K. J., 2nd, Hall, C. D., & Robertson, K. R. (2007). Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease. Journal of Neurovirology, 13(4), 291–304.CrossRefPubMed
Liner, K. J., 2nd, Hall, C. D., & Robertson, K. R. (2008). Effects of antiretroviral therapy on cognitive impairment. Current HIV/AIDS Reports, 5(2), 64–71.CrossRefPubMed
Llorente, A. M., Turcich, M., & Lawrence, K. A. (2004). Differences in neuropsychological performance associated with ethnicity in children with HIV-1 infection: preliminary findings. Applied Neuropsychology, 11(1), 47–53.CrossRefPubMed
Maj, M., Satz, P., Janssen, R., Zaudig, M., Starace, F., D’Elia, L., et al. (1994). WHO neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. Archives of General Psychiatry, 51(1), 51–61.PubMed
Maragos, W. F., Tillman, P., Jones, M., Bruce-Keller, A. J., Roth, S., Bell, J. E., et al. (2003). Neuronal injury in hippocampus with human immunodeficiency virus transactivating protein, Tat. Neuroscience, 117(1), 43–53.CrossRefPubMed
Masliah, E., Ge, N., Achim, C. L., Hansen, L. A., & Wiley, C. A. (1992). Selective neuronal vulnerability in HIV encephalitis. Journal of Neuropathology and Experimental Neurology, 51(6), 585–593.CrossRefPubMed
Masliah, E., Heaton, R. K., Marcotte, T. D., Ellis, R. J., Wiley, C. A., Mallory, M., et al. (1997). Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC group. The HIV neurobehavioral research center. Annals of Neurology, 42(6), 963–972.CrossRefPubMed
Mattson, M. P., Haughey, N. J., & Nath, A. (2005). Cell death in HIV dementia. Cell Death and Differentiation, 12(Suppl 1), 893–904.CrossRefPubMed
Mayes, J. T., Jahoda, G., & Neilson, I. (1988). Patterns of visual-spatial performance and ‘spatial ability’: dissociation of ethnic and sex differences. British Journal of Psychology, 79(Pt 1), 105–119.PubMed
McArthur, J. C., Hoover, D. R., Bacellar, H., Miller, E. N., Cohen, B. A., Becker, J. T., et al. (1993). Dementia in aids patients: incidence and risk factors. Multicenter aids cohort study. Neurology, 43(11), 2245–2252.PubMed
Merrill, J. E., Koyanagi, Y., Zack, J., Thomas, L., Martin, F., & Chen, I. S. (1992). Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. Journal of Virology, 66(4), 2217–2225.PubMed
Mitrushina, M., Boone, K., Razani, J., & D’Elia, L. (2005). Handbook of normative data for neuropsychological assessment (2nd ed.). New York: Oxford University Press, USA.
Mollace, V., Colasanti, M., Persichini, T., Bagetta, G., Lauro, G. M., & Nistico, G. (1993). HIV gp120 glycoprotein stimulates the inducible isoform of no synthase in human cultured astrocytoma cells. Biochemical and Biophysical Research Communications, 194(1), 439–445.CrossRefPubMed
Moore, D. J., Masliah, E., Rippeth, J. D., Gonzalez, R., Carey, C. L., Cherner, M., et al. (2006). Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. Aids, 20(6), 879–887.CrossRefPubMed
Nath, A., Conant, K., Chen, P., Scott, C., & Major, E. O. (1999). Transient exposure to HIV-1 tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. Journal of Biological Chemistry, 274(24), 17098–17102.CrossRefPubMed
Navia, B. A., Cho, E. S., Petito, C. K., & Price, R. W. (1986a). The aids dementia complex: II. Neuropathology. Annals of Neurology, 19(6), 525–535.CrossRefPubMed
Navia, B. A., Jordan, B. D., & Price, R. W. (1986b). The aids dementia complex: I. Clinical features. Annals of Neurology, 19(6), 517–524.CrossRefPubMed
Nisbett, R. E., & Miyamoto, Y. (2005). The influence of culture: holistic versus analytic perception. Trends in Cognitive Sciences, 9(10), 467–473.CrossRefPubMed
Parsons, T. D., Rogers, S., Hall, C., & Robertson, K. (2007). Motor based assessment of neurocognitive functioning in resource-limited international settings. Journal of Clinical and Experimental Neuropsychology, 29(1), 59–66.CrossRefPubMed
Patton, H. K., Zhou, Z. H., Bubien, J. K., Benveniste, E. N., & Benos, D. J. (2000). Gp120-induced alterations of human astrocyte function: Na(+)/h(+) exchange, k(+) conductance, and glutamate flux. American Journal of Physiology-Cell Physiology, 279(3), C700–C708.PubMed
Paul, R. H., Gunstad, J., Cooper, N., Williams, L. M., Clark, C. R., Cohen, R. A., et al. (2007). Cross-cultural assessment of neuropsychological performance and electrical brain function measures: additional validation of an international brain database. International Journal of Neuroscience, 117(4), 549–568.CrossRefPubMed
Portegies, P., Enting, R. H., de Gans, J., Algra, P. R., Derix, M. M., Lange, J. M., et al. (1993). Presentation and course of aids dementia complex: 10 years of follow-up in Amsterdam, the Netherlands. Aids, 7(5), 669–675.CrossRefPubMed
Power, C., Selnes, O. A., Grim, J. A., & McArthur, J. C. (1995). HIV dementia scale: a rapid screening test. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 8(3), 273-278. PubMed
Price, R. W., & Sidtis, J. J. (1990). Evaluation of the aids dementia complex in clinical trials. Journal of Acquired Immune Deficiency Syndromes, 3(Suppl 2), S51–S60.PubMed
Price, R. W., & Spudich, S. (2008). Antiretroviral therapy and central nervous system HIV type 1 infection. Journal of Infectious Diseases, 197(Suppl 3), S294–S306.CrossRefPubMed
Razani, J., Burciaga, J., Madore, M., & Wong, J. (2007a). Effects of acculturation on tests of attention and information processing in an ethnically diverse group. Archives of Clinical Neuropsychology, 22(3), 333–341.CrossRefPubMed
Razani, J., Murcia, G., Tabares, J., & Wong, J. (2007b). The effects of culture on WASI test performance in ethnically diverse individuals. Clinical Neuropsychology, 21(5), 776–788.CrossRef
Robertson, K. R., Nakasujja, N., Wong, M., Musisi, S., Katabira, E., Parsons, T. D., et al. (2007a). Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurology, 7, 8.PubMed
Robertson, K. R., Smurzynski, M., Parsons, T. D., Wu, K., Bosch, R. J., Wu, J., et al. (2007b). The prevalence and incidence of neurocognitive impairment in the HAART era. Aids, 21(14), 1915–1921.CrossRefPubMed
Robertson, K., Kumwenda, J., Supparatpinyo, K., Evans, S., Jiang, J., Campbell, T., et al. (2008). Baseline data from ACTG 5199: The international neurological study. Paper presented at the 15th Conference on Retroviruses and Opportunistic Infections, Boston.
Robertson, K., Jiang, H., Tripathy, S., Santos, B., Silva, M., Montano, S. et al. (2009). Improved neuropsychological function during HAART in diverse resource-limited settings: AIDS clinical trials group study A5199, the international neurological study. Paper presented at the 16 th Conference on Retroviruses and Opportunistic Infections, Montreal.
Rosselli, M., & Ardila, A. (2003). The impact of culture and education on non-verbal neuropsychological measurements: a critical review. Brain and Cognition, 52(3), 326–333.CrossRefPubMed
Rourke, S. B., Halman, M. H., & Bassel, C. (1999). Neurocognitive complaints in HIV-infection and their relationship to depressive symptoms and neuropsychological functioning. Journal of Clinical and Experimental Neuropsychology, 21(6), 737–756.CrossRefPubMed
Sacktor, N., Lyles, R. H., Skolasky, R., Kleeberger, C., Selnes, O. A., Miller, E. N., et al. (2001). HIV-associated neurologic disease incidence changes: multicenter aids cohort study, 1990–1998. Neurology, 56(2), 257–260.PubMed
Sacktor, N., McDermott, M. P., Marder, K., Schifitto, G., Selnes, O. A., McArthur, J. C., et al. (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. Journal of Neurovirology, 8(2), 136–142.CrossRefPubMed
Sacktor, N. C., Wong, M., Nakasujja, N., Skolasky, R. L., Selnes, O. A., Musisi, S., et al. (2005). The international HIV dementia scale: a new rapid screening test for HIV dementia. Aids, 19(13), 1367–1374.PubMed
Sacktor, N., Nakasujja, N., Robertson, K., & Clifford, D. B. (2007). HIV-associated cognitive impairment in sub-Saharan Africa—the potential effect of clade diversity. Nature Clinical Practice Neurology, 3(8), 436–443.CrossRefPubMed
Sadek, J. R., Vigil, O., Grant, I., & Heaton, R. K. (2007). The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence. Journal of Clinical and Experimental Neuropsychology, 29(3), 266–276.CrossRefPubMed
Spreen, O. S. E. (1991). A compendium of neuropsychological tests: Administration, norms, and commentary (2nd ed.). New York: Oxford University Press.
Stern, Y., McDermott, M. P., Albert, S., Palumbo, D., Selnes, O. A., McArthur, J., et al. (2001). Factors associated with incident human immunodeficiency virus-dementia. Archives of Neurology, 58(3), 473–479.CrossRefPubMed
Takahashi, K., Wesselingh, S. L., Griffin, D. E., McArthur, J. C., Johnson, R. T., & Glass, J. D. (1996). Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Annals of Neurology, 39(6), 705–711.CrossRefPubMed
The constitution of India: The official languages act (1963). Government of India Ministry of Law and Justice.
Tozzi, V., Balestra, P., Serraino, D., Bellagamba, R., Corpolongo, A., Piselli, P., et al. (2005). Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. AIDS Research and Human Retroviruses, 21(8), 706–713.CrossRefPubMed
Trillo-Pazos, G., Diamanturos, A., Rislove, L., Menza, T., Chao, W., Belem, P., et al. (2003). Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathology, 13(2), 144–154.PubMedCrossRef
White, D. A., Heaton, R. K., & Monsch, A. U. (1995). Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. The HNRC group. HIV neurobehavioral research center. Journal of the International Neuropsychological Society, 1(3), 304–315.CrossRefPubMed
WHO/UNAIDS (2008). 2008 report on the global aids epidemic.
Wilkie, F. L., Goodkin, K., Ardila, A., Concha, M., Lee, D., Lecusay, R., et al. (2004). Humans: an English and Spanish neuropsychological test battery for assessing HIV-1-infected individuals—initial report. Applied Neuropsychology, 11(3), 121–133.CrossRefPubMed
Woods, S. P., Childers, M., Ellis, R. J., Guaman, S., Grant, I., & Heaton, R. K. (2006). A battery approach for measuring neuropsychological change. Archives of Clinical Neuropsychology, 21(1), 83–89.CrossRefPubMed
Wright, E., Brew, B., Arayawichanont, A., Robertson, K., Samintharapanya, K., Kongsaengdao, S., et al. (2008). Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region. Neurology, 71(1), 50–56.CrossRefPubMed
Yepthomi, T., Paul, R., Vallabhaneni, S., Kumarasamy, N., Tate, D. F., Solomon, S., et al. (2006). Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus. Journal of the International Neuropsychological Society, 12(3), 424–430.CrossRefPubMed
Metadata
Title
Neuropsychological Assessment of HIV-Infected Populations in International Settings
Authors
Kevin Robertson
Jeff Liner
Robert Heaton
Publication date
01-06-2009
Publisher
Springer US
Published in
Neuropsychology Review / Issue 2/2009
Print ISSN: 1040-7308
Electronic ISSN: 1573-6660
DOI
https://doi.org/10.1007/s11065-009-9096-z

Other articles of this Issue 2/2009

Neuropsychology Review 2/2009 Go to the issue

Review

The Neuropsychology of HIV/AIDS in Older Adults

Review

HIV, Cognition and Women

Review

Race-Norming of Neuropsychological Tests

Review

Drug Abuse and Hepatitis C Infection as Comorbid Features of HIV Associated Neurocognitive Disorder: Neurocognitive and Neuroimaging Features

Review

Neuropsychological Functioning and Antiretroviral Treatment in HIV/AIDS: A Review

Review

Functional Consequences of HIV-Associated Neuropsychological Impairment